Hansa Biopharma AB Statistics

Total Valuation

STO:HNSA has a market cap or net worth of SEK 3.40 billion. The enterprise value is 4.07 billion.

Market Cap	3.40B
Enterprise Value	4.07B

Important Dates

The next estimated earnings date is Wednesday, February 11, 2026.

Earnings Date	Feb 11, 2026
Ex-Dividend Date	n/a

Share Statistics

STO:HNSA has 101.76 million shares outstanding. The number of shares has increased by 23.08% in one year.

Current Share Class	101.76M
Shares Outstanding	101.76M
Shares Change (YoY)	+23.08%
Shares Change (QoQ)	+19.72%
Owned by Insiders (%)	5.84%
Owned by Institutions (%)	15.95%
Float	56.91M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	19.03
PB Ratio	-6.06
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-6.35
EV / Sales	22.79
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.11

Current Ratio	1.11
Quick Ratio	1.10
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-5.49

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-42.29%
Return on Invested Capital (ROIC)	-70.95%
Return on Capital Employed (ROCE)	-177.00%
Revenue Per Employee	1.34M
Profits Per Employee	-4.82M
Employee Count	135
Asset Turnover	0.21
Inventory Turnover	26.30

Taxes

In the past 12 months, STO:HNSA has paid 4.71 million in taxes.

Income Tax	4.71M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +6.23% in the last 52 weeks. The beta is 1.82, so STO:HNSA's price volatility has been higher than the market average.

Beta (5Y)	1.82
52-Week Price Change	+6.23%
50-Day Moving Average	32.83
200-Day Moving Average	28.02
Relative Strength Index (RSI)	59.46
Average Volume (20 Days)	555,075

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, STO:HNSA had revenue of SEK 178.61 million and -641.14 million in losses. Loss per share was -8.82.

Revenue	178.61M
Gross Profit	106.22M
Operating Income	-568.93M
Pretax Income	-636.43M
Net Income	-641.14M
EBITDA	-566.58M
EBIT	-568.93M
Loss Per Share	-8.82

Full Income Statement

Balance Sheet

The company has 252.07 million in cash and 923.90 million in debt, giving a net cash position of -671.82 million or -6.60 per share.

Cash & Cash Equivalents	252.07M
Total Debt	923.90M
Net Cash	-671.82M
Net Cash Per Share	-6.60
Equity (Book Value)	-560.74M
Book Value Per Share	-6.62
Working Capital	44.46M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-501.05M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	59.47%
Operating Margin	-318.53%
Pretax Margin	-356.32%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

STO:HNSA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-23.08%
Shareholder Yield	-23.08%
Earnings Yield	-18.86%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	4